Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 253

1.

Coping behaviors and depressive status in individuals with type 2 diabetes mellitus.

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N.

Ann Gen Psychiatry. 2019 Jul 17;18:11. doi: 10.1186/s12991-019-0235-5. eCollection 2019.

2.

8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine.

Shinozaki M, Pierce J, Hayashi Y, Watanabe T, Sasaki T, Komahashi-Sasaki H, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Ozeki Y, Shimoda K.

Pharmacopsychiatry. 2019 Jun 3. doi: 10.1055/a-0918-6408. [Epub ahead of print]

PMID:
31158907
3.

Personality associated with depressive status in individuals with type 2 diabetes mellitus.

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N.

Neuropsychiatr Dis Treat. 2019 May 3;15:1133-1139. doi: 10.2147/NDT.S200012. eCollection 2019.

4.

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia.

Sugawara N, Yasui-Furukori N, Sumiyoshi T.

Front Psychiatry. 2019 Apr 12;10:195. doi: 10.3389/fpsyt.2019.00195. eCollection 2019. Review.

5.

Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report.

Kishi K, Kubo K, Tomita T, Nakamura K, Yasui-Furukori N.

Int Med Case Rep J. 2019 Feb 21;12:51-54. doi: 10.2147/IMCRJ.S200489. eCollection 2019.

6.

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan.

Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2019 Jan 9;15:205-211. doi: 10.2147/NDT.S188337. eCollection 2019.

7.

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff.

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2018 Dec 27;15:137-142. doi: 10.2147/NDT.S185483. eCollection 2019.

8.

Effects of personality on the association between paroxetine plasma concentration and response.

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K.

Neuropsychiatr Dis Treat. 2018 Nov 29;14:3299-3306. doi: 10.2147/NDT.S187060. eCollection 2018.

9.

Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs.

Kumagai F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, Mimura M, Uchida H.

J Clin Psychiatry. 2018 Dec 4;80(1). pii: 18m12144. doi: 10.4088/JCP.18m12144.

PMID:
30549487
10.

Suvorexant-Induced Delirium.

Yoshida K, Nakamura K, Yasui-Furukori N.

Prim Care Companion CNS Disord. 2018 Nov 15;20(6). pii: 18l02297. doi: 10.4088/PCC.18l02297. No abstract available.

11.

Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.

Akamine Y, Yasui-Furukori N, Uno T.

Curr Drug Metab. 2019;20(2):124-129. doi: 10.2174/1389200219666181003142036.

PMID:
30280663
12.

Higher plasma leptin and lower C-peptide levels are associated with depression: A cross-sectional study.

Takekawa D, Kudo T, Saito J, Kimura F, Nikaido Y, Sawada K, Yasui-Furukori N, Hirota K.

J Affect Disord. 2019 Jan 15;243:70-74. doi: 10.1016/j.jad.2018.09.014. Epub 2018 Sep 11.

PMID:
30236760
13.

Tandospirone-Induced Rhabdomyolysis.

Miyazaki K, Otaka M, Yasui-Furukori N.

Clin Neuropharmacol. 2018 Nov/Dec;41(6):216-217. doi: 10.1097/WNF.0000000000000303.

PMID:
30204599
14.

Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus.

Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Yoshida K, Sugawara N, Yasui-Furukori N, Daimon M.

J Diabetes Investig. 2019 Mar;10(2):484-490. doi: 10.1111/jdi.12927. Epub 2018 Oct 24.

15.

Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus.

Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2018 Jul 10;14:1803-1809. doi: 10.2147/NDT.S168934. eCollection 2018.

16.

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.

Ono S, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Okamoto K, Sagae T, Someya T.

BMC Psychiatry. 2018 Jun 8;18(1):180. doi: 10.1186/s12888-018-1764-1.

17.

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients.

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2018 May 22;14:1319-1327. doi: 10.2147/NDT.S158254. eCollection 2018.

18.

Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression.

Tsuchimine S, Ochi S, Tajiri M, Suzuki Y, Sugawara N, Inoue Y, Yasui-Furukori N.

Ther Drug Monit. 2018 Jun;40(3):356-361. doi: 10.1097/FTD.0000000000000506.

19.

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation.

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N.

Neuropsychiatr Dis Treat. 2018 Feb 12;14:505-510. doi: 10.2147/NDT.S156797. eCollection 2018.

20.

Increased levels of CREB in major depressive patients with antidepressant treatment.

Tsuchimine S, Sugawara N, Yasui-Furukori N.

Psychiatry Res. 2018 May;263:296-297. doi: 10.1016/j.psychres.2017.12.077. Epub 2018 Jan 2. No abstract available.

PMID:
29310886

Supplemental Content

Loading ...
Support Center